VCYT - CIK 0001384101
The table below shows VERACYTE, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $136.31M | $75.10M | $44.22M | $7.54M | -$31.62M | -$9.71M |
| Capital expenditure | $9.68M | $11.29M | $9.96M | $8.55M | $5.38M | $2.84M |
| Investing cash flow | -$9.21M | -$56.27M | $15.11M | -$29.39M | -$739.21M | -$3.84M |
| Dividends paid | - | - | - | - | - |
VERACYTE, INC. reported operating cash flow of $136.31M for fiscal year 2025. That is up 81.5% from $75.10M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$27.98M (FY 2016) to $136.31M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$4.22M | $4.90M | $2.84M | $3.49M | $596.32M | $203.59M |